TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
December 4, 2023
By
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
November 30, 2023
By
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 9, 2023
By
TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting
November 6, 2023
By
TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition
November 2, 2023
By
TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting
September 27, 2023
By
TScan Therapeutics to Participate in Upcoming Investor Conferences
September 5, 2023
By
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME
August 29, 2023
By
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 10, 2023
By
TScan Therapeutics Announces Transition of Chief Financial Officer
June 29, 2023
By